Form 8-K Theravance Biopharma, For: Nov 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Theravance Biopharma (TBPH) Tops Q3 EPS by 4c
November 9, 2015 5:06 PM ESTTheravance Biopharma (NASDAQ: TBPH) reported Q3 EPS of ($1.40), $0.04 better than the analyst estimate of ($1.44). Revenue for the quarter came in at $10.7 million versus the consensus estimate of $4.24 million.
For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.
... More